Aromasin · DIN 02242705 · 25 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Aromasin · DIN 02242705
Manufacturer: Pfizer Canada Inc.; listing date 2002-07-29
Health Canada: Marketed since 2004-11-16 · brand AROMASIN · ATC L02BG06 EXEMESTANE · form Tablet · route Oral · ingredients EXEMESTANE 25 MG · company Pfizer canada ulc · schedule Prescription
Ministry pays: $3.1232 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242705)
Source record
DIN 02242705: Aromasin
Raw flags: sec3=Y
Item: 100000162; group id 160; item number 0275; lccId None; manufacturer id PFI
Source form: Tab; strength: 25mg
Recorded listing: General benefit
Source prices (unrounded): $6.3649; ministry $3.1232
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242705
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66502
Interchangeable products
Act Exemestane · DIN 02390183 · $3.1232
Med-Exemestane · DIN 02407841 · $3.1232
Shortage status: resolved shortage (ended October 15, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02242705
Shortage record checked October 6, 2026